Gene · 8451
Papers1,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential mechanisms and application prospects of non-coding RNAs in intervertebral disc degeneration. | Front Endocrinol (Lausanne) | 2022 | 36568075 | PubTator, text mining | PubMed |
| Red blood cell proteomics reveal remnant protein biosynthesis and folding pathways in PIEZO1-related hereditary xerocytosis. | Front Physiol | 2022 | 36531183 | PubTator, text mining | PubMed |
| Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma. | Front Oncol | 2022 | 36530999 | PubTator, text mining | PubMed |
| A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy. | J Exp Clin Cancer Res | 2022 | 36527092 | PubTator, text mining | PubMed |
| Hepatic neddylation deficiency triggers fatal liver injury via inducing NF-κB-inducing kinase in mice. | Nat Commun | 2022 | 36526632 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis identified a novel prognostic pan-programmed cell death signature for bladder cancer. | Front Immunol | 2022 | 36505448 | PubTator, text mining | PubMed |
| Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation. | Genomics Proteomics Bioinformatics | 2022 | 36494034 | PubTator, text mining | PubMed |
| NEDDylated Cullin 3 mediates the adaptive response to topoisomerase 1 inhibitors. | Sci Adv | 2022 | 36490343 | PubTator, text mining | PubMed |
| Targeting CRL4 suppresses chemoresistant ovarian cancer growth by inducing mitophagy. | Signal Transduct Target Ther | 2022 | 36481655 | PubTator, text mining | PubMed |
| Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway. | Cell Biosci | 2022 | 36471438 | PubTator, text mining | PubMed |
| Proteogenomic characterization of MiT family translocation renal cell carcinoma. | Nat Commun | 2022 | 36470859 | PubTator, text mining | PubMed |
| Elevated ubiquitination contributes to protective immunity against severe SARS-CoV-2 infection. | Clin Transl Med | 2022 | 36447039 | PubTator, text mining | PubMed |
| Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myeloma. | Front Oncol | 2022 | 36439455 | PubTator, text mining | PubMed |
| E3 ubiquitin ligases in the acute leukemic signaling pathways. | Front Physiol | 2022 | 36439256 | PubTator, text mining | PubMed |
| Poly ADP-ribosylation of SET8 leads to aberrant H4K20 methylation in mammalian nuclear genome. | Commun Biol | 2022 | 36434141 | PubTator, text mining | PubMed |
| AMPK induces degradation of the transcriptional repressor PROX1 impairing branched amino acid metabolism and tumourigenesis. | Nat Commun | 2022 | 36433955 | PubTator, text mining | PubMed |
| Differential dynamics of cullin deneddylation via COP9 signalosome subunit 5 interaction. | Biochem Biophys Res Commun | 2022 | 36423380 | PubTator, text mining | PubMed |
| Development and validation of a novel ubiquitination-related gene prognostic signature based on tumor microenvironment for colon cancer. | Transl Cancer Res | 2022 | 36388031 | PubTator, text mining | PubMed |
| Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. | Front Oncol | 2022 | 36387095 | PubTator, text mining | PubMed |
| Fusion gene recurrence in non-small cell lung cancers and its association with cigarette smoke exposure. | Transl Lung Cancer Res | 2022 | 36386463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8451/papers?page=12